| 1 | regulation of mesoderm development (GO:2000380) | 6.35841963 |
| 2 | cardiac epithelial to mesenchymal transition (GO:0060317) | 6.35204503 |
| 3 | renal absorption (GO:0070293) | 6.16426998 |
| 4 | anterior/posterior axis specification (GO:0009948) | 6.02740721 |
| 5 | cell migration involved in gastrulation (GO:0042074) | 5.74665901 |
| 6 | primitive streak formation (GO:0090009) | 5.71121567 |
| 7 | sequestering of extracellular ligand from receptor (GO:0035581) | 5.69494143 |
| 8 | cell surface receptor signaling pathway involved in heart development (GO:0061311) | 5.57140356 |
| 9 | endoderm formation (GO:0001706) | 5.42681090 |
| 10 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 5.33014667 |
| 11 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 5.23775217 |
| 12 | somite rostral/caudal axis specification (GO:0032525) | 5.17014066 |
| 13 | gastrulation (GO:0007369) | 5.06151026 |
| 14 | signal transduction involved in regulation of gene expression (GO:0023019) | 4.86733405 |
| 15 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 4.85830372 |
| 16 | regulation of transcription initiation from RNA polymerase II promoter (GO:0060260) | 4.82636757 |
| 17 | regulation of activin receptor signaling pathway (GO:0032925) | 4.81230973 |
| 18 | anterior/posterior axis specification, embryo (GO:0008595) | 4.75547219 |
| 19 | ventricular cardiac muscle cell development (GO:0055015) | 4.74837512 |
| 20 | regulation of transcription from RNA polymerase II promoter involved in heart development (GO:190121 | 4.61770924 |
| 21 | negative regulation of activin receptor signaling pathway (GO:0032926) | 4.54292067 |
| 22 | regulation of DNA-templated transcription, initiation (GO:2000142) | 4.53271165 |
| 23 | positive regulation of catenin import into nucleus (GO:0035413) | 4.44065354 |
| 24 | Notch signaling involved in heart development (GO:0061314) | 4.36365834 |
| 25 | phospholipid scrambling (GO:0017121) | 4.33834326 |
| 26 | cellular response to BMP stimulus (GO:0071773) | 4.33032823 |
| 27 | response to BMP (GO:0071772) | 4.33032823 |
| 28 | negative regulation of axon guidance (GO:1902668) | 4.18300196 |
| 29 | CENP-A containing nucleosome assembly (GO:0034080) | 4.16548791 |
| 30 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 4.13223891 |
| 31 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 4.10514292 |
| 32 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 4.05314205 |
| 33 | chromatin remodeling at centromere (GO:0031055) | 3.96839703 |
| 34 | embryonic axis specification (GO:0000578) | 3.89914402 |
| 35 | regulation of cardiac muscle cell apoptotic process (GO:0010665) | 3.86942106 |
| 36 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.85208346 |
| 37 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.85208346 |
| 38 | cardiac right ventricle morphogenesis (GO:0003215) | 3.83638674 |
| 39 | regulation of smooth muscle cell differentiation (GO:0051150) | 3.81935255 |
| 40 | glomerulus development (GO:0032835) | 3.75669388 |
| 41 | regulation of striated muscle cell apoptotic process (GO:0010662) | 3.72036829 |
| 42 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 3.70825731 |
| 43 | mesenchymal cell development (GO:0014031) | 3.69104499 |
| 44 | gastrulation with mouth forming second (GO:0001702) | 3.66156517 |
| 45 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 3.63579607 |
| 46 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 3.62847523 |
| 47 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 3.62065896 |
| 48 | SMAD protein signal transduction (GO:0060395) | 3.61039592 |
| 49 | axis specification (GO:0009798) | 3.60835484 |
| 50 | positive regulation of urine volume (GO:0035810) | 3.57022371 |
| 51 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.51154664 |
| 52 | cochlea development (GO:0090102) | 3.50337289 |
| 53 | lateral sprouting from an epithelium (GO:0060601) | 3.46443949 |
| 54 | kidney mesenchyme development (GO:0072074) | 3.44681931 |
| 55 | vitamin catabolic process (GO:0009111) | 3.43110757 |
| 56 | fat-soluble vitamin catabolic process (GO:0042363) | 3.43110757 |
| 57 | histone exchange (GO:0043486) | 3.42398550 |
| 58 | cellular response to fluid shear stress (GO:0071498) | 3.42106290 |
| 59 | meiotic chromosome segregation (GO:0045132) | 3.41976659 |
| 60 | metaphase plate congression (GO:0051310) | 3.39436849 |
| 61 | epithelial to mesenchymal transition (GO:0001837) | 3.38258968 |
| 62 | type B pancreatic cell development (GO:0003323) | 3.38232103 |
| 63 | negative regulation of embryonic development (GO:0045992) | 3.37384117 |
| 64 | regulation of centrosome duplication (GO:0010824) | 3.35180771 |
| 65 | telencephalon development (GO:0021537) | 3.33504808 |
| 66 | female gonad development (GO:0008585) | 3.32730763 |
| 67 | regulation of centrosome cycle (GO:0046605) | 3.32396317 |
| 68 | regulation of centriole replication (GO:0046599) | 3.20849183 |
| 69 | DNA double-strand break processing (GO:0000729) | 3.16563435 |
| 70 | embryonic foregut morphogenesis (GO:0048617) | 3.15974921 |
| 71 | smooth muscle cell differentiation (GO:0051145) | 3.15031756 |
| 72 | dorsal/ventral axis specification (GO:0009950) | 3.14473380 |
| 73 | mesenchymal cell differentiation (GO:0048762) | 3.14398444 |
| 74 | cardiac muscle adaptation (GO:0014887) | 3.13964148 |
| 75 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.13964148 |
| 76 | muscle hypertrophy in response to stress (GO:0003299) | 3.13964148 |
| 77 | DNA replication-independent nucleosome organization (GO:0034724) | 3.12517192 |
| 78 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.12517192 |
| 79 | cardiac left ventricle morphogenesis (GO:0003214) | 3.11733768 |
| 80 | positive regulation of cardiac muscle tissue development (GO:0055025) | 3.09531811 |
| 81 | positive regulation of cardiac muscle cell proliferation (GO:0060045) | 3.08664649 |
| 82 | uterus development (GO:0060065) | 3.08074076 |
| 83 | atrial cardiac muscle cell action potential (GO:0086014) | 3.06644364 |
| 84 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 3.05560586 |
| 85 | isotype switching (GO:0045190) | 3.05560586 |
| 86 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 3.05560586 |
| 87 | metanephric mesenchyme development (GO:0072075) | 3.04576647 |
| 88 | pattern specification involved in kidney development (GO:0061004) | 3.04365121 |
| 89 | heart valve formation (GO:0003188) | 3.04062102 |
| 90 | bone morphogenesis (GO:0060349) | 3.02909925 |
| 91 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 3.02475251 |
| 92 | extracellular regulation of signal transduction (GO:1900115) | 3.02247536 |
| 93 | extracellular negative regulation of signal transduction (GO:1900116) | 3.02247536 |
| 94 | organ formation (GO:0048645) | 3.01324042 |
| 95 | DNA replication checkpoint (GO:0000076) | 3.01290837 |
| 96 | regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393) | 3.00462515 |
| 97 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.98215998 |
| 98 | positive regulation of meiosis (GO:0045836) | 2.97591830 |
| 99 | positive regulation of p38MAPK cascade (GO:1900745) | 2.97399167 |
| 100 | mesenchymal to epithelial transition (GO:0060231) | 2.96181240 |
PSKH2 
